Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
100 results
  • Lung Cancer

19-368          Phase II

A Biomarker-Directed Phase 2 Platform Study in Patients with Advanced Non-Small Cell Lung Cancer whose Disease has Progressed on First-Line Osimertinib Therapy (ORCHARD) (View details on clinicaltrial.gov)

  • Melanoma

20-675          Phase II

A Blinded, Randomized Phase 2 Study of Troriluzole in Combination with Ipilimumab and Nivolumab in Patients with Melanoma Brain Metastases previously treated with anti-PD-1 therapy (View details on clinicaltrial.gov)

  • Ovarian Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on clinicaltrial.gov)

  • Cervical Cancer, Gastric (Stomach) Cancer, Liver Cancer

20-577          Phase I

A First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Ovarian Cancer, Head and Neck Cancer, Breast Cancer, Cervical Cancer

21-689          Phase I

A First-in-Human Study of Mutant-selective PI3Ka Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer (View details on clinicaltrial.gov)

  • Lymphoma, Melanoma, Lung Cancer, Kidney Cancer, Bladder Cancer

21-481          Phase I

A First-in-Human, Multicenter, Open-Label, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAB004 as Monotherapy and in Combination with Toripalimab in Subjects with Advanced Solid Malignancies including Lymphoma (View details on clinicaltrial.gov)

  • Colorectal Cancer, Lung Cancer

20-177          Phase I

A First-in-Human, Phase 1a/1b, Open-Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients with Advanced or Refractory Tumors (View details on clinicaltrial.gov)

Showing 1 - 10 of 100 results